- Home
- LNTH vs BILL Comparison
LNTH vs BILL Comparison
Compare LNTH & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BILL
- Stock Information
- Founded
- LNTH 1956
- BILL 2006
- Country
- LNTH United States
- BILL United States
- Employees
- LNTH N/A
- BILL N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BILL EDP Services
- Sector
- LNTH Health Care
- BILL Technology
- Exchange
- LNTH Nasdaq
- BILL Nasdaq
- Market Cap
- LNTH 6.0B
- BILL 5.9B
- IPO Year
- LNTH 2015
- BILL 2019
- Fundamental
- Price
- LNTH $78.23
- BILL $52.75
- Analyst Decision
- LNTH Strong Buy
- BILL Buy
- Analyst Count
- LNTH 6
- BILL 19
- Target Price
- LNTH $132.67
- BILL $81.72
- AVG Volume (30 Days)
- LNTH 832.8K
- BILL 4.2M
- Earning Date
- LNTH 02-26-2025
- BILL 02-06-2025
- Dividend Yield
- LNTH N/A
- BILL N/A
- EPS Growth
- LNTH 304.57
- BILL N/A
- EPS
- LNTH 6.02
- BILL 0.39
- Revenue
- LNTH $1,496,799,000.00
- BILL $1,387,696,000.00
- Revenue This Year
- LNTH $19.64
- BILL $15.41
- Revenue Next Year
- LNTH $5.16
- BILL $15.45
- P/E Ratio
- LNTH $12.99
- BILL $135.15
- Revenue Growth
- LNTH 24.15
- BILL 16.42
- 52 Week Low
- LNTH $56.44
- BILL $43.11
- 52 Week High
- LNTH $126.89
- BILL $100.19
- Technical
- Relative Strength Index (RSI)
- LNTH 31.32
- BILL 19.82
- Support Level
- LNTH $79.39
- BILL $58.67
- Resistance Level
- LNTH $84.24
- BILL $61.21
- Average True Range (ATR)
- LNTH 3.84
- BILL 2.97
- MACD
- LNTH -0.93
- BILL -2.87
- Stochastic Oscillator
- LNTH 0.66
- BILL 0.90
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.